Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Ribose phosphate)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004476 AN007503 The effect of acute AKT inhibition on global metabolism in primary rat hepatocytes Cultured cells Rat University of Pennsylvania LC-MS
ST004424 AN007401 Stereochemistry-Driven Design and Synthesis of Tadalafil Analogues as Antiplasmodial Agents Plasmodium cells Parasite Malaria Pennsylvania State University LC-MS
ST004135 AN006855 The SLC1A1/EAAT3 Dicarboxylic Amino Acid Transporter is an Epigenetically Dysregulated Nutrient Carrier that Sustains Oncogenic Metabolic Programs Cultured cells Human Cancer Cleveland Clinic LC-MS
ST004017 AN006622 Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistance Infected Red Blood Cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST004017 AN006623 Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistance Infected Red Blood Cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST003665 AN006022 The effects of cystine limitation stress adaptation (CLSA) on metabolomics changes in pancreatic cancer cells (PANC1) Cultured cells Human Cancer Pennsylvania State University LC-MS
ST003642 AN005981 Hexosamine Biosynthesis Disruption Impairs GPI Production and Arrests Plasmodium falciparum Growth at Schizont Stages Cultured cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST003638 AN005975 The effects of cystine limitation stress adaptation (CLSA) on metabolomics changes in pancreatic cancer cells (MiaPaCa-2) Pancreas Human Cancer Pennsylvania State University LC-MS
ST003224 AN005286 The Ataxia-Telangiectasia Mutated Kinase Inhibitor AZD0156 is a Potent Inhibitor of Plasmodium Phosphatidylinositol 4-Kinase and is an Attractive Candidate for Repositioning Against Malaria Cultured cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST002936 AN004816 O-GlcNAcase activity maintains stress granules for proximity-enhanced ATP production to ensure recovery from stress (Part 2) Cultured cells Human Zhejiang University LC-MS
ST002813 AN004576 Effects of acute cold exposure on mouse metabolome BAT Mouse University of Pennsylvania LC-MS
ST002813 AN004576 Effects of acute cold exposure on mouse metabolome Blood Mouse University of Pennsylvania LC-MS
ST002813 AN004576 Effects of acute cold exposure on mouse metabolome Diaphragm Mouse University of Pennsylvania LC-MS
ST002813 AN004576 Effects of acute cold exposure on mouse metabolome gWAT Mouse University of Pennsylvania LC-MS
ST002813 AN004576 Effects of acute cold exposure on mouse metabolome Heart Mouse University of Pennsylvania LC-MS
ST002813 AN004576 Effects of acute cold exposure on mouse metabolome Liver Mouse University of Pennsylvania LC-MS
ST002813 AN004576 Effects of acute cold exposure on mouse metabolome Quadriceps Mouse University of Pennsylvania LC-MS
ST002805 AN004561 IL-1β-mediated adaptive re-programming of endogenous human cardiac fibroblasts to cells with immune features during fibrotic remodeling Cultured cells Human Pulmonary hypertension Brown University Other
ST002375 AN003870 Metabolomics analysis of WT or GOT1 knockout CD8+ T cells cultured in serine-replete or serine-free media Cultured cells Mouse Johns Hopkins University LC-MS
ST002374 AN003869 Metabolomics analysis of WT vs. GOT1 knockout CD8+ T cells Cultured cells Mouse Johns Hopkins University LC-MS
ST002373 AN003868 Extracellular metabolome of activated CD8+ T cells Cultured cells Mouse Johns Hopkins University LC-MS
ST002371 AN003866 High-resolution metabolomics analysis of NLRP3 inflammasome activated macrophages Macrophages Mouse Inflammation Wake Forest School of Medicine GC-MS
ST002123 AN003476 GCN2 regulates mitochondrial OXPHOS in HSPCs under proliferation conditions. Bone marrow Mouse Sun Yat-sen University LC-MS
ST002119 AN003468 Metabolomics analysis of zebrafish response to CID661578 treatment Larvae Zebrafish Diabetes North Carolina State University LC-MS
ST002115 AN003513 LC-MS analysis of metabolic changes induced by GPX4 inhibitor treatment in cultured HT1080 cells Cultured cells Human University of Texas MD Anderson Cancer Center LC-MS
ST002078 AN003387 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST002078 AN003388 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST002078 AN003389 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST002078 AN003390 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST002024 AN003294 Plasmodium falciparum stable-isotope carbon labeling to explore metabolic consequences of keto–acid dehydrogenase disruption Cultured cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST002011 AN003277 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST002011 AN003278 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST002011 AN003279 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Blood Human Malaria Pennsylvania State University LC-MS
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Blood Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Cultured cells Human Malaria Pennsylvania State University LC-MS
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Cultured cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST001908 AN003105 Post Acute Myocardial Infarction Left Ventricular Remodeling Bio marker Analysis (PAMILA) Blood Human Heart disease National University of Singapore LC-MS
ST001714 AN002789 Metabolomic Profiling of Atovaquone and Atovaquone-like Resistance Lines Parasite Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST001714 AN002790 Metabolomic Profiling of Atovaquone and Atovaquone-like Resistance Lines Parasite Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST001714 AN002791 Metabolomic Profiling of Atovaquone and Atovaquone-like Resistance Lines Parasite Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST001611 AN002646 Mouse model of sarcoma (STS) to characterize tumor vulnerabilities and identify novel targets for anti-cancer treatment Muscle Mouse Cancer North Carolina State University LC-MS
ST001611 AN002646 Mouse model of sarcoma (STS) to characterize tumor vulnerabilities and identify novel targets for anti-cancer treatment Sarcoma Mouse Cancer North Carolina State University LC-MS
ST001441 AN002408 Metabolomics of patient-derived fibroblasts Fibroblast cells Human Mitochondrial disease North Carolina State University LC-MS
ST001382 AN002303 Distinct metabolic states of a cell guide alternate fates of mutational buffering through altered proteostasis Bacterial cells Escherichia coli CSIR-National Chemical Laboratory LC-MS
ST001232 AN002050 Combining stage - specificity and metabolomic profiling to advance drug discovery for malaria Cultured cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST001149 AN001896 Plasmodium Niemann-Pick Type C1-Related Protein is a Druggable Target Required for Parasite Membrane Homeostasis Cultured cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
ST001074 AN001756 Open source discovery of starting points for next generation chemoprotective antimalarial drugs (Biofocus 1) Parasite Human Pennsylvania State University LC-MS
ST000441 AN000692 Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways Plasmodium cells Plasmodium falciparum Malaria Pennsylvania State University LC-MS
  logo